GSK-690693
-
Catalog number2272-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol
-
DescriptionAn ATP-competitive pan-Akt kinase inhibitor. Inhibits Akt kinase isoforms 1, 2, 3 with IC₅₀ values of 2, 13, and 9 nM, respectively. Inhibited proliferation and induced apoptosis in a subset of tumor cells with potency consistent with intracellular inhibition of Akt kinase activity.
-
CAS Number937174-76-0
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₇N₇O₃
-
Molecular Weight425.48
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~20 mg/ml)
-
HandlingProtect from air and moisture
-
Tag LineA pan-Akt kinase inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD14105605
-
PubChem CID16725726
-
SMILESCCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
-
InChiInChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1
-
InChi KeyKGPGFQWBCSZGEL-ZDUSSCGKSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK-690693
-
Alternative nameGSK-690693
-